Teva Pharmaceutical Finance Netherlands III B.V.
Indicative
Full Lot
Indicative price as of 02 Oct 2026, 4:33pm
Ask Yield to Worst
Bid Yield to Worst
Ask Yield to Maturity
Bid Yield to Maturity
Bond Issuer
Teva Pharmaceutical Finance Netherlands III B.V.
Guarantor
Teva Pharmaceutical Industries Ltd
Announcement Date
02 Nov 2021
Issue Date
09 Nov 2021
Maturity Date
09 May 2027
Years to Maturity / Next Call
0.593 / 0.349
Modified Duration
0.567 @ 02 Oct 2026
Issue / Reoffer Price
100.000
Issue / Reoffer Yield
4.750
Coupon Type
Fixed
Annual Coupon Rate
4.750
Coupon Frequency
Semi Annually
Seniority
Senior Unsecured
Reference Rate
-
ISIN
US88167AAP66
CUSIP
88167AAP6
Bond Currency
USD
Total Issue Size
1,000,000,000
Outstanding Issue Size
649,123,000
Min. Investment Quantity (Nominal)
USD 200,000
Incremental Quantity (Nominal)
USD 1,000
Bond Type
Corporate
Bond Sector
Health Care
Bond Sub Sector
Pharmaceuticals
Issuer Credit Rating (S&P/ Fitch)
***/ N.R
Bond Credit Rating (S&P/ Fitch)
***/ BBB-
Shariah Compliant
No
Exchange Listed
Others
“Par Call Date” means (i) with respect to the 2027 USD notes February 9, 2027 (the date that is three months prior to the maturity date of the 2027 USD notes) and (ii) with respect to the 2029 USD notes February 9, 2029 (the date that is three months prior to the maturity date of the 2029USD notes).
“Par Call Date” means (i) with respect to the 2027 USD notes February 9, 2027 (the date that is three months prior to the maturity date of the 2027 USD notes) and (ii) with respect to the 2029 USD notes February 9, 2029 (the date that is three months prior to the maturity date of the 2029USD notes).
Cash Flow Information